rosiglitazone has been researched along with natriuretic peptide, brain in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gardner, DG; Liang, F; Wang, F; Zhang, S | 1 |
| Abdel-Latif, A; AlMahameed, A; Bhatt, DL; Blankenship, JC; Brennan, D; Chew, DP; Corbelli, JC; Eres, A; Gilchrist, IC; Grines, C; Hazen, SL; Leesar, M; McErlean, E; Mukherjee, D; Resar, JR; Steinhubl, S; Tan, WA; Tang, HW; Tang, WH; Topol, EJ | 1 |
| Atar, A; Biyiklioglu, Z; Dogruk Unal, A; Güvener Demirag, N; Türkmen Kemal, Y; Yildirir, A | 1 |
| Hu, M; Luo, Y; Tian, H; Wu, W; Zhang, H; Zhou, X | 1 |
| Achouba, A; Arsenault, M; Brûlé, S; Couet, J; Deshaies, Y; Festuccia, WT; Guerra-Sá, R; Houde, VP; Lachance, D; Laplante, M; Marette, A; Pedrosa, ML; Silva, ME | 1 |
| Abdullah, SM; Armstead, SI; Ayers, CR; de Lemos, JA; Gore, MO; Khera, A; McGavock, J; McGuire, DK; Narang, N; See, R; Snell, PG; Stream, A | 1 |
| Bao, Y; Jia, W; Lu, J; Zhou, J; Zhou, M | 1 |
5 trial(s) available for rosiglitazone and natriuretic peptide, brain
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Diseases; Coronary Disease; Disease Progression; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Middle Aged; Natriuretic Peptide, Brain; Pilot Projects; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2007 |
Effects of rosiglitazone on plasma brain natriuretic peptide levels and myocardial performance index in patients with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Echocardiography; Female; Glycated Hemoglobin; Heart; Heart Function Tests; Humans; Hypoglycemic Agents; Male; Middle Aged; Natriuretic Peptide, Brain; Rosiglitazone; Thiazolidinediones; Ventricular Function, Left | 2007 |
[Effect of insulin plus rosiglitazone or metformin on serum N-terminal pro-brain natriuretic peptide in type 2 diabetes mellitus: a randomized-controlled study].
Topics: Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Rosiglitazone; Thiazolidinediones | 2008 |
Assessment of cardiac structure and function in patients without and with peripheral oedema during rosiglitazone treatment.
Topics: Aged; Biomarkers; Chi-Square Distribution; Diabetes Mellitus, Type 2; Edema; Exercise Test; Female; Heart Failure; Hematocrit; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Oxygen Consumption; Plasma Volume; Prospective Studies; Rosiglitazone; Serum Albumin; Single-Blind Method; Stroke Volume; Texas; Thiazolidinediones; Time Factors; Ventricular Function; Weight Gain | 2011 |
Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone.
Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fatty Acid-Binding Proteins; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Receptor Cross-Talk; Rosiglitazone; Thiazolidinediones | 2011 |
2 other study(ies) available for rosiglitazone and natriuretic peptide, brain
| Article | Year |
|---|---|
Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
Topics: Animals; Animals, Newborn; Base Sequence; Cell Size; Cells, Cultured; Fenofibrate; Gene Expression; Heart Ventricles; Hypertrophy; Hypoglycemic Agents; Hypolipidemic Agents; Ligands; Molecular Sequence Data; Mutagenesis, Site-Directed; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peroxisome Proliferators; Pyrimidines; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sarcomeres; Thiazoles; Thiazolidinediones; Transcription Factors | 2003 |
Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation.
Topics: Animals; Atrial Natriuretic Factor; Blotting, Western; Body Weight; Cardiomegaly; Eating; Echocardiography; Glucosyltransferases; Glycogen; Glycogen Phosphorylase; Glycogen Synthase; Glycoproteins; Hemodynamics; Hypoglycemic Agents; Lipoprotein Lipase; Male; Myofibrils; Natriuretic Peptide, Brain; Proteasome Endopeptidase Complex; Protein Kinases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; TOR Serine-Threonine Kinases; UTP-Glucose-1-Phosphate Uridylyltransferase | 2009 |